Sphingolipidoses  >>  evacetrapib (LY2484595)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
evacetrapib (LY2484595) / Eli Lilly
NCT02168803: A Study of Evacetrapib in Participants With Abnormal Cholesterol

Completed
1b
101
US
Evacetrapib, LY2484595
Eli Lilly and Company
Dyslipidemia
12/15
12/15

Download Options